HealthDay on MSN2h
Infectious Diseases Society of America, Oct. 16-19
The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 16 to 19 in Los Angeles, ...
News Medical4h
Researchers decode MRSA biofilm structure to combat antibiotic resistance
Imagine falling seriously ill with an infection. Normally, we visit the doctor, are prescribed antibiotics, and after 7-10 days, we're back on our feet.
News Medical4h
Antibiotic for liver disease linked to emergence of antimicrobial resistant superbug
An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form ...
Intermountain Health researchers receive major grant to study methods to establish long-term antibiotic stewardship in urgent care settings
Researchers at Intermountain Health have been awarded a $356,000 grant from Merck, a global science and technology company ...
'Low risk' antibiotic has led to an almost untreatable superbug, study finds
A new study has found that an antibiotic for liver disease patients could expose them to greater risk of a dangerous superbug.
EurekAlert!2d
‘Low risk’ antibiotic has led to an almost untreatable superbug
The study has demonstrated that rifaximin usage is driving resistance to daptomycin, one of the last effective antibiotics ...
Monthly Prescribing Reference2d
IDSA: Antibiotics for 7 Days Feasible for Patients Hospitalized With Bloodstream Infections
HealthDay News — Treating hospitalized patients with bloodstream infections with antibiotics for 7 days is noninferior to ...